{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:30:21Z","timestamp":1790163021247,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2003,5,27]],"date-time":"2003-05-27T00:00:00Z","timestamp":1053993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1038\/sj.npp.1300250","type":"journal-article","created":{"date-parts":[[2003,7,16]],"date-time":"2003-07-16T10:34:41Z","timestamp":1058351681000},"page":"1866-1870","source":"Crossref","is-referenced-by-count":72,"title":["The Effect of Cabergoline on Sleep, Periodic Leg Movements in Sleep, and Early Morning Motor Function in Patients with Parkinson's Disease"],"prefix":"10.1038","volume":"28","author":[{"given":"Birgit","family":"H\u00f6gl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rothdach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C","family":"Wetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Trenkwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,5,27]]},"reference":[{"key":"BF1300250_CR1","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1001\/archneur.1994.00540240080020","volume":"51","author":"JE Ahlskog","year":"1994","unstructured":"Ahlskog JE, Muenter MD, Maraganore DM, Matsumoto JY, Lieberman A, Wright KF et al (1994). Fluctuating Parkinson's disease. Treatment with the long-acting dopamine agonist cabergoline. Arch Neurol 51: 1236\u20131241.","journal-title":"Arch Neurol"},{"key":"BF1300250_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1600-0404.1993.tb04095.x","volume":"87","author":"JJ Askenasy","year":"1993","unstructured":"Askenasy JJ (1993). Sleep in Parkinson's disease. Acta Neurol Scand 87: 167\u2013170.","journal-title":"Acta Neurol Scand"},{"key":"BF1300250_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF01255413","volume":"59","author":"JJ Askenasy","year":"1984","unstructured":"Askenasy JJ, Yahr MD (1984). Suppression of REM rebound by pergolide. J Neural Transm 59: 151\u2013159.","journal-title":"J Neural Transm"},{"key":"BF1300250_CR4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/sleep\/16.8.748","volume":"16","author":"C Guilleminault","year":"1993","unstructured":"Atlas Task Force of the American Sleep Disorders Association Guilleminault C (1993). Recording and scoring leg movements. Sleep 16: 748\u2013759.","journal-title":"Sleep"},{"key":"BF1300250_CR5","doi-asserted-by":"crossref","unstructured":"Atlas Task Force of the American Sleep Disorders Association (1992). EEG arousals: scoring rules and examples. Sleep 15: 173\u2013184.","DOI":"10.1093\/sleep\/15.2.173"},{"key":"BF1300250_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1046\/j.1365-2869.1998.00119.x","volume":"7","author":"M Blagrove","year":"1998","unstructured":"Blagrove M, Owens DS, MacDonald I, Sytnik N, Tucker P, Folkard S (1998). Time of day effects in, and the relationship between, sleep quality and movement. J Sleep Res 7: 233\u2013239.","journal-title":"J Sleep Res"},{"key":"BF1300250_CR7","first-page":"671","volume":"23","author":"DL Bliwise","year":"2000","unstructured":"Bliwise DL, Willians ML, Irbe D, Ansari FP, Rye DB (2000). Inter-rater reliability for identification of REM sleep in Parkinson's disease. Sleep 23: 671\u2013676.","journal-title":"Sleep"},{"key":"BF1300250_CR8","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/mds.10242","volume":"17","author":"H Brunner","year":"2002","unstructured":"Brunner H, Wetter TC, Hogl B, Yassouridis A, Trenkwalder C, Friess E (2002). Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: effects of dopaminergic treatment. Movement Disord 17: 928\u2013933.","journal-title":"Movement Disord"},{"key":"BF1300250_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF00427596","volume":"67","author":"C Cianchetti","year":"1980","unstructured":"Cianchetti C, Masala C, Mangoni A, Gessa GL (1980). Suppression of REM and delta sleep by apomorphine in man: a dopamine mimetic effect. Psychopharmacology 67: 61\u201365.","journal-title":"Psychopharmacology"},{"key":"BF1300250_CR10","first-page":"519","volume":"53","author":"C Chouza","year":"1990","unstructured":"Chouza C, Aljanati R, Caamano JL, De Medina O, Scaramelli A, Buzo R et al (1990). Long-term treatment with Madopar HBS in parkinsonians with fluctuations. Adv Neurol 53: 519\u2013526.","journal-title":"Adv Neurol"},{"key":"BF1300250_CR11","first-page":"153","volume-title":"Recent Development in Parkinson's Disease","author":"S Fahn","year":"1987","unstructured":"Fahn S, Elton RL, Members of the UPDRS development committee (1987). Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent Development in Parkinson's Disease, Vol. 2 MacMillan Healthcare Information: Florham Park, NJ. pp 153\u2013163; 293\u2013304."},{"key":"BF1300250_CR12","unstructured":"Fariello RG (1998). Pharmacodynamic and pharmacokinetic features of cabergoline. Rationale for use in Parkinson's disease. Drugs (Suppl 1): 10\u201316."},{"key":"BF1300250_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/ana.1119","volume":"50","author":"A Freeman","year":"2001","unstructured":"Freeman A, Ciliax B, Bakay R, Daley J, Miller RD, Keating G et al (2001). Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models. Ann Neurol 50: 321\u2013329.","journal-title":"Ann Neurol"},{"key":"BF1300250_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1600-0404.1987.tb03546.x","volume":"76","author":"A Laihinen","year":"1987","unstructured":"Laihinen A, Alihanka J, Raitasuo S, Rinne UK (1987). Sleep movements and associated autonomic nervous activities in patients with Parkinson's disease. Acta Neurol Scand 76: 64\u201368.","journal-title":"Acta Neurol Scand"},{"key":"BF1300250_CR15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1212\/WNL.42.7.1371","volume":"42","author":"O Lapierre","year":"1992","unstructured":"Lapierre O, Montplaisir J (1992). Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology 42: 1371\u20131374.","journal-title":"Neurology"},{"key":"BF1300250_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/00002826-198812000-00004","volume":"11","author":"AJ Lees","year":"1988","unstructured":"Lees AJ, Blackburn NA, Campbell VL (1988). The nighttime problems of Parkinson's disease. Clin Neuropharmacol 11: 512\u2013519.","journal-title":"Clin Neuropharmacol"},{"key":"BF1300250_CR17","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1212\/WNL.43.12.2587","volume":"43","author":"G Lera","year":"1993","unstructured":"Lera G, Vaamonde J, Rodriguez M, Obeso JA (1993). Cabergoline in Parkinson's disease: long-term follow-up. Neurology 43: 2587\u20132590.","journal-title":"Neurology"},{"key":"BF1300250_CR18","first-page":"574","volume-title":"Principles and Practice of Sleep Medicine","author":"M Mahowald","year":"1995","unstructured":"Mahowald M, Schenck CH (1995). REM sleep behavior disorder. In: Kryger M, Roth T, Dement W (eds) Principles and Practice of Sleep Medicine, 2nd edn WB Saunders: Philadelphia. pp 574\u2013588."},{"key":"BF1300250_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1389-9457(00)00014-9","volume":"1","author":"J Montplaisir","year":"2000","unstructured":"Montplaisir J, Michaud M, Denesle R, Gosselin A (2000). Periodic leg movements are not more prevalent in insomnia or hypersomnia but are specifically associated with sleep disorders involving a dopaminergic impairment. Sleep Med 1: 163\u2013167.","journal-title":"Sleep Med"},{"key":"BF1300250_CR20","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1212\/WNL.52.5.938","volume":"52","author":"J Montplaisir","year":"1999","unstructured":"Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B (1999). Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 52: 938\u2013943.","journal-title":"Neurology"},{"key":"BF1300250_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1212\/WNL.43.4.677","volume":"43","author":"R Pahwa","year":"1993","unstructured":"Pahwa R, Busenbark K, Huber SJ, Michalek D, Hubble JP, Koller WC (1993). Clinical experience with controlled-release carbidopa\/levodopa in Parkinson's disease. Neurology 43: 677\u2013681.","journal-title":"Neurology"},{"key":"BF1300250_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/00019052-200008000-00009","volume":"13","author":"W Poewe","year":"2000","unstructured":"Poewe W, H\u00f6gl B (2000). Parkinson's disease and sleep. Curr Opin Neurol 13: 423\u2013426.","journal-title":"Curr Opin Neurol"},{"key":"BF1300250_CR23","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1212\/WNL.57.2.300","volume":"57","author":"F Provini","year":"2001","unstructured":"Provini F, Vetrugno R, Meletti S, Plazzi G, Solieri L, Lugaresi E et al (2001). Motor pattern of periodic limb movements during sleep. Neurology 57: 300\u2013304.","journal-title":"Neurology"},{"key":"BF1300250_CR24","volume-title":"A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects","author":"A Rechtschaffen","year":"1968","unstructured":"Rechtschaffen A, Kales A (eds) (1968). A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Brain Information Service\/Brain Research Institute, University of California: Los Angeles."},{"key":"BF1300250_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1212\/WNL.58.3.341","volume":"58","author":"DB Rye","year":"2002","unstructured":"Rye DB, Jankovic J (2002). Emerging views of dopamine in modulation sleep\/wake state from an unlikely source: PD. Neurology 58: 341\u2013346.","journal-title":"Neurology"},{"key":"BF1300250_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/sleep\/23.3.1b","volume":"23","author":"K Stiasny","year":"2000","unstructured":"Stiasny K, Robbecke J, Schuler P, Oertel WH (2000). Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline\u2014an open clinical trial. Sleep 23: 349\u2013354.","journal-title":"Sleep"},{"key":"BF1300250_CR27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/mds.870130606","volume":"13","author":"E Tandberg","year":"1998","unstructured":"Tandberg E, Larsen JP, Karlsen K (1998). A community-based study of sleep disorders in patients with Parkinson's disease. Movement Disord 13: 895\u2013899.","journal-title":"Movement Disord"},{"key":"BF1300250_CR28","first-page":"107","volume":"5","author":"C Trenkwalder","year":"1998","unstructured":"Trenkwalder C (1998). Sleep dysfunction in Parkinson's disease. Clin Neurosci 5: 107\u2013114.","journal-title":"Clin Neurosci"},{"key":"BF1300250_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-3-642-57836-6_4","volume-title":"The Pharmacology of Sleep. Handbook of Experimental Pharmacology","author":"A Wauquier","year":"1995","unstructured":"Wauquier A (1995). Pharmacology of the catecholaminergic system. In: Kales AD (ed) The Pharmacology of Sleep. Handbook of Experimental Pharmacology, Vol. 116 Springer: Berlin, Heidelberg: New York. pp 65\u201385."},{"key":"BF1300250_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/sleep\/23.3.1c","volume":"23","author":"TC Wetter","year":"2000","unstructured":"Wetter TC, Collado-Seidel V, Pollm\u00e4cher T, Yassouridis A, Trenkwalder C (2000). Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 23: 361\u2013367.","journal-title":"Sleep"},{"key":"BF1300250_CR31","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1212\/WNL.52.5.944","volume":"52","author":"TC Wetter","year":"1999","unstructured":"Wetter TC, Stiasny K, Winkelmann J, Buhlinger A, Brandenburg U, Penzel T et al (1999). A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 52: 944\u2013950.","journal-title":"Neurology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300250","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:44:36Z","timestamp":1684219476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,27]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["BF1300250"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300250","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,27]]}}}